Market Overview:
The global genomic workstation market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for precision medicine, rising prevalence of chronic diseases, and growing focus on personalized medicine. In addition, technological advancements in genomic workstation are also contributing to the growth of this market. Based on type, the global genomic workstation market is segmented into fully automatic and semi-automatic segments. The fully automatic segment is expected to account for a larger share of the global genomic workstation market than the semi-automatic segment during the forecast period. This can be attributed to factors such as ease of use and accuracy offered by fully automatic machines over semi-automatic machines. Based on application, the global genomic workstation market is divided into laboratory applications, clinical applications, pharmaceutical applications, and other applications segments.
Product Definition:
A Genomic Workstation is a computer system specifically designed for the analysis of genomic data. It typically includes software for managing and analyzing large datasets, as well as tools for visualizing genomic information. The importance of a Genomic Workstation lies in its ability to help researchers rapidly identify regions of the genome that are associated with particular traits or diseases.
Fully Automatic:
Fully automatic systems are those that can perform a task without any further user intervention. The fully automatic system is witnessing growth in the market due to its advantages such as high speed, accuracy and cost-effectiveness over semi-automatic systems. Fully automated workstations provide results in less time which is driving the market growth factor.
Semi Automatic:
Semi-automatic is a tool that can be used in genomic workstation. It's an advanced version of the fully automatic system and it has some advantages over the latter such as it requires less human intervention, provides high accuracy, and offers quick results.
The market for semi-automated systems is expected to witness significant growth during the forecast period owing to its increasing demand in research & development activities across various industry verticals including pharmaceuticals & biotechnology.
Application Insights:
The laboratory application segment accounted for the largest revenue share in 2016 and is anticipated to continue its dominance over the forecast period. The growing demand for sequencing capabilities has fueled this growth. The ability of genetic workstations to process a large number of samples at a go is also likely to be a major factor driving their adoption in laboratories across the globe.
Clinical applications are expected to witness substantial growth over the forecast period owing to an increase in demand for precision medicine, which requires high-throughput genomic technologies. This segment is further divided into cancer, infectious diseases, hematology & oncology, endocrinology & metabolism and neurology & neurobiology segments based on application needs.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to presence of key players, high investment in R&D and well-established healthcare infrastructure. Furthermore, increasing number of genomic procedures is anticipated to drive the regional demand for automated instruments over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising prevalence of chronic diseases coupled with growing awareness about available treatment options and availability of advanced technologies such as next-generation sequencing (NGS). In addition, economic development in countries such as India & China has led these nations being a hub for outsourcing services which will further boost revenue generation within region’s scope.
Growth Factors:
- Increasing demand for personalized medicine
- Advances in genomic sequencing technology
- Growing number of genetic disorders and cancer cases
- Rising public and private investments in genomics research
- Proliferation of genomics data sharing initiatives
Scope Of The Report
Report Attributes
Report Details
Report Title
Genomic Workstation Market Research Report
By Type
Fully Automatic, Semi Automatic
By Application
Laboratory, Clinical, Pharmaceutical, Others
By Companies
Danaher Corporation (Beckman Coulter), Aurora, Synthetic Genomics, Inc., PerkinElmer Inc., Fluent, Tecan Group, Thermo Scientific, Hudson Robotics, LGC Ltd, Endress+Hauser (Analytik Jena), Danaher Corporation (Beckman Coulter)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Genomic Workstation Market Report Segments:
The global Genomic Workstation market is segmented on the basis of:
Types
Fully Automatic, Semi Automatic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory, Clinical, Pharmaceutical, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Danaher Corporation (Beckman Coulter)
- Aurora
- Synthetic Genomics, Inc.
- PerkinElmer Inc.
- Fluent
- Tecan Group
- Thermo Scientific
- Hudson Robotics
- LGC Ltd
- Endress+Hauser (Analytik Jena)
- Danaher Corporation (Beckman Coulter)
Highlights of The Genomic Workstation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fully Automatic
- Semi Automatic
- By Application:
- Laboratory
- Clinical
- Pharmaceutical
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Genomic Workstation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Genomic Workstation is a software application used for the analysis and interpretation of genomic data. It provides an integrated platform for managing and analyzing sequencing data, including assembly, annotation, variant detection and genotyping.
Some of the major players in the genomic workstation market are Danaher Corporation (Beckman Coulter), Aurora, Synthetic Genomics, Inc., PerkinElmer Inc., Fluent, Tecan Group, Thermo Scientific, Hudson Robotics, LGC Ltd, Endress+Hauser (Analytik Jena), Danaher Corporation (Beckman Coulter).
The genomic workstation market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Genomic Workstation Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Genomic Workstation Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Genomic Workstation Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Genomic Workstation Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Genomic Workstation Market Size & Forecast, 2018-2028
4.5.1 Genomic Workstation Market Size and Y-o-Y Growth
4.5.2 Genomic Workstation Market Absolute $ Opportunity
Chapter 5 Global Genomic Workstation Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Genomic Workstation Market Size Forecast by Type
5.2.1 Fully Automatic
5.2.2 Semi Automatic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Genomic Workstation Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Genomic Workstation Market Size Forecast by Applications
6.2.1 Laboratory
6.2.2 Clinical
6.2.3 Pharmaceutical
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Genomic Workstation Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Genomic Workstation Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Genomic Workstation Analysis and Forecast
9.1 Introduction
9.2 North America Genomic Workstation Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Genomic Workstation Market Size Forecast by Type
9.6.1 Fully Automatic
9.6.2 Semi Automatic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Genomic Workstation Market Size Forecast by Applications
9.10.1 Laboratory
9.10.2 Clinical
9.10.3 Pharmaceutical
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Genomic Workstation Analysis and Forecast
10.1 Introduction
10.2 Europe Genomic Workstation Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Genomic Workstation Market Size Forecast by Type
10.6.1 Fully Automatic
10.6.2 Semi Automatic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Genomic Workstation Market Size Forecast by Applications
10.10.1 Laboratory
10.10.2 Clinical
10.10.3 Pharmaceutical
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Genomic Workstation Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Genomic Workstation Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Genomic Workstation Market Size Forecast by Type
11.6.1 Fully Automatic
11.6.2 Semi Automatic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Genomic Workstation Market Size Forecast by Applications
11.10.1 Laboratory
11.10.2 Clinical
11.10.3 Pharmaceutical
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Genomic Workstation Analysis and Forecast
12.1 Introduction
12.2 Latin America Genomic Workstation Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Genomic Workstation Market Size Forecast by Type
12.6.1 Fully Automatic
12.6.2 Semi Automatic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Genomic Workstation Market Size Forecast by Applications
12.10.1 Laboratory
12.10.2 Clinical
12.10.3 Pharmaceutical
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Genomic Workstation Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Genomic Workstation Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Genomic Workstation Market Size Forecast by Type
13.6.1 Fully Automatic
13.6.2 Semi Automatic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Genomic Workstation Market Size Forecast by Applications
13.10.1 Laboratory
13.10.2 Clinical
13.10.3 Pharmaceutical
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Genomic Workstation Market: Competitive Dashboard
14.2 Global Genomic Workstation Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Danaher Corporation (Beckman Coulter)
14.3.2 Aurora
14.3.3 Synthetic Genomics, Inc.
14.3.4 PerkinElmer Inc.
14.3.5 Fluent
14.3.6 Tecan Group
14.3.7 Thermo Scientific
14.3.8 Hudson Robotics
14.3.9 LGC Ltd
14.3.10 Endress+Hauser (Analytik Jena)
14.3.11 Danaher Corporation (Beckman Coulter)
